Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC44970Sulfosuccinimidyl Myristate (sodium salt)CAS: 162823-01-0纯度: >95.00%
An inhibitor of fatty acid transport
- GC44975SW203668 (trifluoroacetate salt)CAS: 2117405-48-6纯度: >98.00%
An irreversible inhibitor of stearoyl-CoA desaturase
- GC44993Taurocholic Acid (sodium salt)CAS: 145-42-6纯度: >95.00% / >97.00% / >98.00%
Taurocholic Acid (sodium salt)是一种牛磺酸结合形式的主要胆汁酸，具有显著的生物活性作用。
- GC44996Taurolithocholic Acid (sodium salt)CAS: 6042-32-6纯度: >98.00%
Taurolithocholic Acid (sodium salt)是一种强效的，可帮助吸收肠道中脂质和甾醇的牛磺酸共轭胆汁酸。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC44901 | SLM6031434 | 1897379-33-7 | >98.00% | |
A selective inhibitor of SPHK2 | ||||
| GC44902 | SLP7111228 (hydrochloride) | 1449768-48-2 | >95.00% | |
A potent and selective SPHK1 inhibitor | ||||
| GC44905 | SMI-481 | 432020-20-7 | >98.00% | |
An inhibitor of Sec14 | ||||
| GC44924 | Sphinganine (d17:0) | 32164-02-6 | >95.00% | |
A bioactive sphingolipid | ||||
| GC44925 | Sphinganine (d20:0) | 24006-62-0 | >98.00% | |
A sphingolipid pathway intermediate | ||||
| GC44926 | Sphinganine-1-phosphate (d17:0) | 474923-29-0 | >95.00% | |
A sphingolipid | ||||
| GC44927 | Sphinganine-1-phosphate (d18:0) | 19794-97-9 | >95.00% | |
A bioactive sphingolipid | ||||
| GC44929 | Sphingosine (d12:1) | 128427-86-1 | >95.00% | |
A short-chain sphingolipid | ||||
| GC44930 | Sphingosine (d14:1) | 24558-60-9 | >98.00% | |
A bioactive sphingolipid | ||||
| GC44931 | Sphingosine (d15:1) | 86555-28-4 | >98.00% | |
15 Carbon sphingosine | ||||
| GC44932 | Sphingosine (d17:1) | 6918-48-5 | >98.00% | |
17 Carbon sphingosine | ||||
| GC44933 | Sphingosine (d18:1) Alkyne | 954096-91-4 | >95.00% | |
An ω-alkyne form of sphingosine (d18:1) | ||||
| GC44934 | Sphingosine-1-phosphate (d16:1) | 709026-60-8 | >95.00% | |
A derivative of S1P | ||||
| GC44935 | Sphingosine-1-phosphate (d17:1) | 474923-27-8 | >95.00% | |
A synthetic sphingolipid | ||||
| GC44943 | sPLA2 Inhibitor | 393569-31-8 | >95.00% | |
An orally active inhibitor of sPLA 2 -IIA | ||||
| GC44950 | Stearidonoyl Glycine | - | >98.00% | |
Stearidonic acid conjugated with glycine | ||||
| GC44952 | Sterculic Acid | 738-87-4 | >98.00% | |
A cyclopropane fatty acid | ||||
| GC44969 | Sulforhodamine 101 DHPE | 187099-99-6 | >95.00% | |
A fluorescent probe | ||||
| GC44970 | Sulfosuccinimidyl Myristate (sodium salt) | 162823-01-0 | >95.00% | |
An inhibitor of fatty acid transport | ||||
| GC44975 | SW203668 (trifluoroacetate salt) | 2117405-48-6 | >98.00% | |
An irreversible inhibitor of stearoyl-CoA desaturase | ||||
| GC44985 | Tafluprost ethyl ester | 209860-89-9 | >98.00% | |
A prostaglandin PGF 2α analog | ||||
| GC44991 | Taprostene (free acid) | 108945-35-3 | >95.00% | |
Stable prostacyclin analog | ||||
| GC44993 | Taurocholic Acid (sodium salt) | 145-42-6 | >95.00% / >97.00% / >98.00% | |
Taurocholic Acid (sodium salt)是一种牛磺酸结合形式的主要胆汁酸，具有显著的生物活性作用。 | ||||
| GC44996 | Taurolithocholic Acid (sodium salt) | 6042-32-6 | >98.00% | |
Taurolithocholic Acid (sodium salt)是一种强效的，可帮助吸收肠道中脂质和甾醇的牛磺酸共轭胆汁酸。 | ||||